
A before-and-after cohort study of more than 18,000 patients found that universal aspirin 162 mg dispensation at the first prenatal visit was associated with a 29% reduction in preeclampsia with severe features, with benefit observed across patients with and without chronic hypertension and no increase in hemorrhagic complications.



